Literature DB >> 28739866

What a neurologist should know about depression in Parkinson's disease.

Monique H M Timmer1,2,3, Maria H C T van Beek1, Bas R Bloem2,3, Rianne A J Esselink2,3.   

Abstract

Depression is a frequent non-motor symptom of Parkinson's disease. Its prevalence varies widely across studies (between 2.7% and 90%); around 35% have clinically significant depressive symptoms. Although depression can have an immense impact on the quality of life of affected patients and their caregivers, depressive symptoms in Parkinson's disease frequently remain unrecognised and, as a result, remain untreated. Here we overview the diagnostic challenges and pitfalls, including the factors contributing to the underdiagnosis of depression. We also discuss current ideas on the underlying pathophysiology. Finally, we offer a treatment approach based on currently available evidence. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  depression; parkinsons’s diesease

Mesh:

Year:  2017        PMID: 28739866     DOI: 10.1136/practneurol-2017-001650

Source DB:  PubMed          Journal:  Pract Neurol        ISSN: 1474-7758


  18 in total

1.  A dyadic study of psychological well-being of individuals with Parkinson's disease and their caregivers.

Authors:  Yu Lee; Yu-Jie Chiou; Chi-Fa Hung; Yung-Yee Chang; Ying-Fa Chen; Tsu-Kung Lin; Liang-Jen Wang
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

Review 2.  Assessment and Management of Neuropsychiatric Symptoms in Parkinson's Disease.

Authors:  Christoph Mueller; Anto P Rajkumar; Yi Min Wan; Latha Velayudhan; Dominic Ffytche; Kallol Ray Chaudhuri; Dag Aarsland
Journal:  CNS Drugs       Date:  2018-07       Impact factor: 5.749

Review 3.  Neuropsychiatric aspects of Parkinson's disease.

Authors:  Anna Nagy; Anette Schrag
Journal:  J Neural Transm (Vienna)       Date:  2019-05-29       Impact factor: 3.575

Review 4.  Neuropalliative Care: A Practical Guide for the Neurologist.

Authors:  K Brizzi; C J Creutzfeldt
Journal:  Semin Neurol       Date:  2018-10-15       Impact factor: 3.420

5.  Comparison of the Effects of COVID-19 Pandemic on Male and Female Gender in Patients Diagnosed with Idiopathic Parkinson's Disease: A Case of Sakarya Province, Turkey.

Authors:  Yeşim Güzey Aras; Belma Doğan Güngen; Türkan Acar; Bilgehan A Acar; Sena Boncuk; Halil A Eryilmaz
Journal:  Noro Psikiyatr Ars       Date:  2022-08-19       Impact factor: 1.066

6.  The Impact of Non-dopaminergic Medication on Quality of Life in Parkinson's Disease.

Authors:  Nicol G M Oonk; Kris L L Movig; Job van der Palen; Henk-Willem Nijmeijer; Mirjam E van Kesteren; Lucille D A Dorresteijn
Journal:  Clin Drug Investig       Date:  2021-08-10       Impact factor: 2.859

7.  Glycyrrhizic Acid Alleviates 6-Hydroxydopamine and Corticosterone-Induced Neurotoxicity in SH-SY5Y Cells Through Modulating Autophagy.

Authors:  Guangyi Yang; Jing Li; Youli Cai; Zhonghua Yang; Rong Li; Wenjun Fu
Journal:  Neurochem Res       Date:  2018-09-11       Impact factor: 3.996

8.  Depression and Related Factors in Patients with Parkinson's Disease at High Altitude.

Authors:  Yu Cao; Gongfeng Li; Jinsheng Xue; Guijuan Zhang; Sensen Gao; Yuling Huang; Aiqin Zhu
Journal:  Neuropsychiatr Dis Treat       Date:  2021-05-06       Impact factor: 2.570

9.  Self-reported and experimentally induced self-disgust is heightened in Parkinson's disease: Contribution of behavioural symptoms.

Authors:  Marianna Tsatali; Paul G Overton; Ana B Vivas
Journal:  PLoS One       Date:  2019-10-16       Impact factor: 3.240

10.  The Impact of the COVID-19 Pandemic on Parkinson's Disease: Hidden Sorrows and Emerging Opportunities.

Authors:  Rick C Helmich; Bastiaan R Bloem
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.